Swine Flu Immunization Program: Supplemental Hearings Before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, Second Session ...
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
U.S. Government Printing Office, 1976 - 572페이지
다른 사람들의 의견 - 서평 쓰기
서평을 찾을 수 없습니다.
기타 출판본 - 모두 보기
action administration American appropriate asked associated assume basis benefits CARTER caused Chairman CHEEK claims clinical committee companies compensation concern consumer contract COOPER costs County court coverage dangerous Davis decision defective defendant Department determine developed discussion disease doses drug duty effect event evidence expected fact failure Federal flu vaccine give given going Government held hospital immunization immunization program individual influenza injury involved issue Laboratories legislation limited loss MAGUIRE malpractice manufacturer mass meet million negligence participation patient percent person physician plaintiff polio population possible present president problem proposed protection public health question reactions reason received reported responsibility result risk ROGERS statement strict liability suits supra swine flu Thank tion tort United vaccine virus warning warranty
444 페이지 - ... (2) The rule stated in Subsection (1) applies although (a) the seller has exercised all possible care in the preparation and sale of his product, and (b) the user or consumer has not bought the product from or entered into any contractual relation with the seller.
360 페이지 - A physician violates his duty to his patient and subjects himself to liability if he withholds any facts which are necessary to form the basis of an intelligent consent by the patient to the proposed treatment.
145 페이지 - There are some products which, in the present state of human knowledge, are quite incapable of being made safe for their intended and ordinary use. These are especially common in the field of drugs. An outstanding example is the vaccine for the Pasteur treatment of rabies, which not uncommonly leads to very serious and damaging consequences when it is injected. Since the disease itself invariably leads to a dreadful death, both the marketing and the...
152 페이지 - There must be reasonable evidence of negligence; but where the thing is shown to be under the management of the defendant or his servants, and the accident is such as in the ordinary course of things does not happen if those who have the management use proper care, it affords reasonable evidence, in the absence of explanation by the defendant, that the accident arose from want of care.
144 페이지 - A manufacturer is strictly liable in tort when an article he places on the market, knowing that it is to be used without inspection for defects, proves to have a defect that causes injury to a human being.
324 페이지 - Subrogation. In the event of any payment under this policy, the company shall be subrogated to all the insured's rights of recovery therefor against any person or organization and the insured shall execute and deliver instruments and papers and do whatever else is necessary to secure such rights. The insured shall do nothing after loss to prejudice such rights.
533 페이지 - One who sells any product in a defective condition unreasonably dangerous to the user or consumer or to his property is subject to liability for physical harm thereby caused to the ultimate user or consumer, or to his property, if (a) the seller is engaged in the business of selling such a product, and (b) it is expected to and does reach the user or consumer without substantial change in the condition in which it is sold.
30 페이지 - ... based upon the exercise or performance or the failure to exercise or perform a discretionary functi'on or duty on the part of a federal agency or an employee of the Goverr., ment, whether or not the discretion involved be abused.
349 페이지 - It would be unjust to recognize a rule that would permit manufacturers of goods to create a demand for their products by representing that they possess qualities which they, in fact, do not possess, and then, because there is no privity of contract existing between the consumer and the manufacturer, deny the consumer the right to recover if damages result from the absence of those qualities, when such absence is not readily noticeable.